Sanofi U.S. Services, INC.
Multinational Pharmaceutical Company.
Based in DC
🤖
AI Overview
With $1.6M in lobbying spend across 28 quarterly filings, Sanofi U.S. Services, INC is a significant lobbying presence. Their lobbying covers 7 issue areas. Active from 2019 to 2025.
$1.6M
Total Spend
7
Years Active
1
Firms Hired
2
Lobbyists Deployed
7
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $140K |
| 2020 | $240K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy, Trade, Taxation and 2 more
- •Healthcare policy issues as they relate to the pharmaceutical industry including research and development, pricing, value and reimbursement. Corporate tax issues.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.